Pain

Pain management protocols for women undergoing C-sections, that include a non-opioid option such as EXPAREL, can help improve pain management and reduce the need for opioids.

Galcanezumab was previously given a Breakthrough Therapy Designation for this indication.

Investigators found that the prevalence of asthma in patients with opioid dependence was more than double the national prevalence.

An investigational non-opioid pain medication, tanezumab demonstrated statistically significant pain reduction at 16 weeks compared to placebo.

William Lennarz, MD, describes the efforts among those in the specialty to reduce pain and anxiety during children's visits to the emergency room.

The updated software will begin being implemented this month for use with the Prometra Pump System.

Reformulation of OxyContin to prevent it being dissolved and injected prompted switching to heroin and a surge in hepatitis C infections.

Heart patients discharged from the hospital with an opioid prescription were less likely to participate in planned follow-up care than those without prescribed opioids.

The soon-to-be marketed therapy Dsuvia has shown enough benefit, tolerability, and safety to aid an at-need patient population in a controlled setting.

A new study found the biggest burden of benzodiazepine-related visits have come from primary care physicians, and that efforts to limit sedative prescription may have to start there.

While studies suggest buprenorphine may be the optimal pharmaceutical treatment for NAS, nonpharmacological approaches may be just as effective.

A series of recently presented studies support the notion of treating hepatitis C in patients already on opioid substitution therapy.

The Second Chance app from University of Washington investigators is seeking FDA consideration in the near future.

Crizanlizumab is being developed to prevent painful and unpredictable vaso-occlusive crises in patients with sickle cell disease.

The FDA has approved 2 new dosages of the pain reliever that combines benzhydrocodone and acetaminophen.

New research finds patients face a higher risk of pneumonia if they are taking opioids. The danger is even more pronounced for patients living with HIV.

MD Magazine's most popular stories this year ranged from new clinical insights, to physician-submitted columns, to perspectives on burnout in the workplace.

A step-by-step look into how Arctic Surgery Group treats postoperative patients.

How an Alaska-based surgical group responded to the opioid epidemic with a multi-step strategy of pain management care.

The guidance touches on hand hygiene, airway management, environmental disinfection, and IV drug injection recommendations.

In a clinical trial, the reSET-O app increased retention in an outpatient opioid use disorder treatment program.

The FDA has approved Dextenza, a dexamethasone ophthalmic insert, for the treatment of ocular pain following ophthalmic surgery.

Martha L. Twaddle, MD, reviews new updates in the 4th edition of National Clinical Guidelines for Palliative Care.

Ronald Gentile, MD, and colleagues investigated pain-reduction strategies following intravitreal injections. The results have implications for patient experience, physician ratings, and treatment adherence.

The SynchroMed II myPTM Personal Therapy Manager allows patients with chronic pain to manage unpredictable pain by delivering on-demand doses within limits set by their provider.